PW Medtech Group Ltd. is an investment holding company, which engages in the manufacture and sale of infusion set products. It operates through the following segments: Infusion Set Business, Blood Purification Business, and Regenerative Medical Biomaterials Business. The Infusion Set Business segment represents the R&D, manufacturing and sales of advanced infusion set, intravenous cannula products, insulin needles. The Blood Purification Business segment represents the R&D, manufacturing and sales of hemodialysis and blood purification medical devices. The Regenerative Medical Biomaterials Business” segment represents the R&D and manufacturing of animal-derived tissue regenerative medical biomaterials and human tissue repair alternative product. The company was founded on May 13, 2011 and is headquartered in Beijing, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company